Pomerantz investigates Kemper over potential securities fraud
Pomerantz LLP is investigating Kemper Corporation for potential securities fraud after the company disclosed increased liability limits leading to higher loss costs. Kemper's stock dropped 10.28% on May 7, 2026, following the announcement. The investigation focuses on whether officers and directors engaged in unlawful business practices.

*this image is generated using AI for illustrative purposes only.
Pomerantz LLP is investigating claims on behalf of investors of Kemper Corporation concerning potential securities fraud or other unlawful business practices by the company and its officers and directors. The investigation follows a disclosure by Kemper regarding increased minimum liability limits that led to higher loss costs and greater attorney involvement in claims. The law firm is advising affected investors to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
On May 6, 2026, Kemper disclosed that the increase in minimum liability limits effective January 1, 2025, has resulted in greater attorney involvement in claims and higher loss costs. Management admitted that this trend has developed over several quarters. Kemper also stated that although the relevant California rate filing was 6.9% in aggregate, it was about 50 points on bodily injury.
Following this news, Kemper’s stock price fell $3.37 per share, or 10.28%, to close at $29.40 per share on May 7, 2026. The decline reflects investor concerns over the financial impact of the increased liability limits and the associated rise in loss costs.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is recognized as a premier firm in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, the firm has a long history of recovering multimillion-dollar damages awards for class members. The firm continues to fight for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct.
| Metric | Value |
|---|---|
| Stock Price Decline | $3.37 per share |
| Percentage Decline | 10.28% |
| Closing Price (May 7, 2026) | $29.40 per share |
| California Rate Filing | 6.9% aggregate |
| Bodily Injury Points | About 50 points |
How will Kemper adjust its pricing strategy and rate filings in other states to offset the rising loss costs?
What is the expected timeline for the Pomerantz LLP investigation, and could it lead to a formal class-action lawsuit?
Will the trend of increased attorney involvement in claims spread beyond California to other jurisdictions?

























